203 related articles for article (PubMed ID: 26067856)
1. Tyrosine Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of Granulosa Cell Tumors of the Ovary.
Jamieson S; Fuller PJ
Int J Gynecol Cancer; 2015 Sep; 25(7):1224-31. PubMed ID: 26067856
[TBL] [Abstract][Full Text] [Related]
2. Endogenous c-Jun N-terminal kinase (JNK) activity marks the boundary between normal and malignant granulosa cells.
Bildik G; Akin N; Senbabaoglu F; Esmalian Y; Sahin GN; Urman D; Karahuseyinoglu S; Ince U; Palaoglu E; Taskiran C; Arvas M; Guzel Y; Yakin K; Oktem O
Cell Death Dis; 2018 Apr; 9(4):421. PubMed ID: 29549247
[TBL] [Abstract][Full Text] [Related]
3. Expression, mutational analysis and in vitro response of imatinib mesylate and nilotinib target genes in ovarian granulosa cell tumors.
Chu S; Alexiadis M; Fuller PJ
Gynecol Oncol; 2008 Jan; 108(1):182-90. PubMed ID: 18028988
[TBL] [Abstract][Full Text] [Related]
4. Combined PPARγ Activation and XIAP Inhibition as a Potential Therapeutic Strategy for Ovarian Granulosa Cell Tumors.
Leung DTH; Nguyen T; Oliver EM; Matti J; Alexiadis M; Silke J; Jobling TW; Fuller PJ; Chu S
Mol Cancer Ther; 2019 Feb; 18(2):364-375. PubMed ID: 30530769
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the inhibitor of kappaB kinase (IKK) complex in granulosa cell tumors of the ovary and granulosa cell tumor-derived cell lines.
Jamieson S; Fuller PJ
Horm Cancer; 2013 Oct; 4(5):277-92. PubMed ID: 23674259
[TBL] [Abstract][Full Text] [Related]
6. 17β-estradiol inhibits spreading of metastatic cells from granulosa cell tumors through a non-genomic mechanism involving GPER1.
François CM; Wargnier R; Petit F; Goulvent T; Rimokh R; Treilleux I; Ray-Coquard I; Zazzu V; Cohen-Tannoudji J; Guigon CJ
Carcinogenesis; 2015 May; 36(5):564-73. PubMed ID: 25823895
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of human granulosa cell tumor cells to epidermal growth factor receptor inhibition.
Andersson N; Anttonen M; Färkkilä A; Pihlajoki M; Bützow R; Unkila-Kallio L; Heikinheimo M
J Mol Endocrinol; 2014 Apr; 52(2):223-34. PubMed ID: 24463098
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor alpha (TGFα) regulates granulosa cell tumor (GCT) cell proliferation and migration through activation of multiple pathways.
Wang C; Lv X; Jiang C; Cordes CM; Fu L; Lele SM; Davis JS
PLoS One; 2012; 7(11):e48299. PubMed ID: 23155381
[TBL] [Abstract][Full Text] [Related]
9. Effects of an inhibitor of the γ-secretase complex on proliferation and apoptotic parameters in a FOXL2-mutated granulosa tumor cell line (KGN).
Irusta G; Pazos MC; Abramovich D; De Zúñiga I; Parborell F; Tesone M
Biol Reprod; 2013 Jul; 89(1):9. PubMed ID: 23699387
[TBL] [Abstract][Full Text] [Related]
10. Anti-Müllerian hormone inhibits growth of AMH type II receptor-positive human ovarian granulosa cell tumor cells by activating apoptosis.
Anttonen M; Färkkilä A; Tauriala H; Kauppinen M; Maclaughlin DT; Unkila-Kallio L; Bützow R; Heikinheimo M
Lab Invest; 2011 Nov; 91(11):1605-14. PubMed ID: 21808236
[TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibition by bortezomib decreases proliferation and increases apoptosis in ovarian granulosa cell tumors.
Chu S; Alexiadis M; Fuller PJ
Reprod Sci; 2009 Apr; 16(4):397-407. PubMed ID: 19087975
[TBL] [Abstract][Full Text] [Related]
12. Expression status and mutational analysis of the PTEN and P13K subunit genes in ovarian granulosa cell tumors.
Bittinger S; Alexiadis M; Fuller PJ
Int J Gynecol Cancer; 2009 Apr; 19(3):339-42. PubMed ID: 19407556
[TBL] [Abstract][Full Text] [Related]
13. Inhibitor of apoptosis proteins are potential targets for treatment of granulosa cell tumors - implications from studies in KGN.
Bagnjuk K; Kast VJ; Tiefenbacher A; Kaseder M; Yanase T; Burges A; Kunz L; Mayr D; Mayerhofer A
J Ovarian Res; 2019 Aug; 12(1):76. PubMed ID: 31412918
[TBL] [Abstract][Full Text] [Related]
14. Serum vascular endothelial growth factor A (VEGF) is elevated in patients with ovarian granulosa cell tumor (GCT), and VEGF inhibition by bevacizumab induces apoptosis in GCT in vitro.
Färkkilä A; Pihlajoki M; Tauriala H; Bützow R; Leminen A; Unkila-Kallio L; Heikinheimo M; Anttonen M
J Clin Endocrinol Metab; 2011 Dec; 96(12):E1973-81. PubMed ID: 21994955
[TBL] [Abstract][Full Text] [Related]
15. RUNX3 Promotes the Tumorigenic Phenotype in KGN, a Human Granulosa Cell Tumor-Derived Cell Line.
Chen H; Crosley P; Azad AK; Gupta N; Gokul N; Xu Z; Weinfeld M; Postovit LM; Pangas SA; Hitt MM; Fu Y
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31311113
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin-mediated sensitivity to TRAIL-induced cell death in human granulosa tumor cells.
Woods DC; Alvarez C; Johnson AL
Gynecol Oncol; 2008 Mar; 108(3):632-40. PubMed ID: 18191995
[TBL] [Abstract][Full Text] [Related]
17. Third-line chemotherapy with tyrosine kinase inhibitor (imatinib mesylate) in recurrent ovarian granulosa cell tumor: case report.
Raspagliesi F; Martinelli F; Grijuela B; Guadalupi V
J Obstet Gynaecol Res; 2011 Dec; 37(12):1864-7. PubMed ID: 21955167
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumors.
Rocconi RP; Matthews KS; Kimball KJ; Conner MG; Baker AC; Barnes MN
Reprod Sci; 2008 Sep; 15(7):673-7. PubMed ID: 18492696
[TBL] [Abstract][Full Text] [Related]
19. Mixtures of persistent organic pollutants increase ovarian granulosa tumor cell line migration and spheroid invasion by upregulating MMP2 expression and activity via IGF1R.
Gogola-Mruk J; Hoffmann-Młodzianowska M; Kamińska K; Ptak A
Toxicology; 2021 Mar; 452():152715. PubMed ID: 33571556
[TBL] [Abstract][Full Text] [Related]
20. YAP regulates cell proliferation, migration, and steroidogenesis in adult granulosa cell tumors.
Fu D; Lv X; Hua G; He C; Dong J; Lele SM; Li DW; Zhai Q; Davis JS; Wang C
Endocr Relat Cancer; 2014 Apr; 21(2):297-310. PubMed ID: 24389730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]